A standardized kodecyte method to quantify ABO antibodies in undiluted plasma of patients before ABO‐incompatible kidney transplantation-Reference-Cited by-同舟云学术

A standardized kodecyte method to quantify ABO antibodies in undiluted plasma of patients before ABO‐incompatible kidney transplantation

Published:2019-03-15 Issue: Volume: Page:
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Perry Holly¹²,Bovin Nicolai²³,Henry Stephen²

Affiliation:

1. School of Science, Faculty of Health and Environmental SciencesAuckland University of Technology Auckland New Zealand

2. Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative TechnologiesAuckland University of Technology Auckland New Zealand

3. Shemyakin Institute of Bioorganic Chemistry Moscow Russian Federation

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15247

Reference54 articles.

2. Mollison's Blood Transfusion in Clinical Medicine

3. Current experience with renal transplantation across the ABO barrier;Nelson PW;Am J Surg,1992

4. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange;Warren DS;Immunol Res,2010

5. Three‐year outcomes following 1420 ABO‐incompatible living‐donor kidney transplants performed after ABO antibody reduction: results from 101 centers;Opelz G;Transplantation,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Resolution of an Epitope Recognized by Blood Group Antibodies Capable of Binding Both A and B Red Blood Cells;ChemBioChem;2024-08-14

2. Synthesis of Glycolipid Analogs Containing A (Type 2) Tetrasaccharide;Russian Journal of Bioorganic Chemistry;2023-08

3. Synthesis of Synthethic Analogs of Glycolipids Containing A (Type 2) Tetrasaccharide;Биоорганическая химия;2023-07-01

4. National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies;Transfusion;2022-09-28

5. Screening of group O platelet donors for high-titer ABO antibodies- limitations, feasibility, and future;Transfusion and Apheresis Science;2022-08